AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity - 04/12/23
Abstract |
An archetypal anti-inflammatory compound against cytokine storm would inhibit it without suppressing the innate immune response. AG5, an anti-inflammatory compound, has been developed as synthetic derivative of andrographolide, which is highly absorbable and presents low toxicity. We found that the mechanism of action of AG5 is through the inhibition of caspase-1. Interestingly, we show with in vitro generated human monocyte derived dendritic cells that AG5 preserves innate immune response. AG5 minimizes inflammatory response in a mouse model of lipopolysaccharide (LPS)-induced lung injury and exhibits in vivo anti-inflammatory efficacy in the SARS-CoV-2-infected mouse model. AG5 opens up a new class of anti-inflammatories, since contrary to NSAIDs, AG5 is able to inhibit the cytokine storm, like dexamethasone, but, unlike corticosteroids, preserves adequately the innate immunity. This is critical at the early stages of any naïve infection, but particularly in SARS-CoV-2 infections. Furthermore, AG5 showed interesting antiviral activity against SARS-CoV-2 in humanized mice.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | AG5, a synthetic derivative of andrographolide, is a novel anti-inflammatory drug |
• | AG5 minimizes inflammatory response by inhibition of caspase-1 route |
• | AG5 inhibits cytokine storm and preserves adequately the innate immunity |
• | AG5 shows antiviral activity against SARS-CoV-2. |
Keywords : Inflammation, Cytokine storm, COVID-19, Andrographolide, Dexamethasone, Innate Immunity
Plan
Vol 169
Article 115882- décembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?